Page last updated: 2024-08-24

trifluoperazine hydrochloride and triparanol

trifluoperazine hydrochloride has been researched along with triparanol in 1 studies

*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]

*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartl, N; Bracher, F; Giera, M; Hemmers, S; Körner, A; Mirakaj, V; Müller, C; Plodek, A1

Other Studies

1 other study(ies) available for trifluoperazine hydrochloride and triparanol

ArticleYear
New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Animals; Desmosterol; Enzyme Inhibitors; HL-60 Cells; Humans; Inhibitory Concentration 50; Mice; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Spectrum Analysis

2017